Warning: The NCBI web site requires JavaScript to function. more...
Generate a file for use with external citation management software.
Nodulisporisteriods A and B, the First 3,4-Seco-4-Methyl-Progesteroids from Nodulisporium sp.1.
Zheng QC, Chen GD, Kong MZ, Li GQ, Cui JY, Li XX, Wu ZY, Guo LD, Cen YZ, Zheng YZ, Gao H.
Steroids. 2013 May 16. doi:pii: S0039-128X(13)00107-4. 10.1016/j.steroids.2013.05.007. [Epub ahead of print]
Related citations
Effect of Epigallocatechin-3-Gallate on Graft-versus-Host Disease.
Choi J, Cooper ML, Ziga ED, Ritchey J, Dipersio JF.
Cell Transplant. 2013 May 14. [Epub ahead of print]
Inhibition of Hedgehog/Gli Signaling by Botanicals: A Review of Compounds with Potential Hedgehog Pathway Inhibitory Activities.
Drenkhahn SK, Jackson GA, Slusarz A, Starkey NJ, Lubahn DB.
Curr Cancer Drug Targets. 2013 May 9. [Epub ahead of print]
Natural Compounds May Open New Routes to Treatment of Amyloid Diseases.
Bieschke J.
Neurotherapeutics. 2013 May 14. [Epub ahead of print]
Epigallocatechin gallate protects against nitric oxide-induced apoptosis via scavenging ROS and modulating the Bcl-2 family in human dental pulp cells.
Young Park S, Jeong YJ, Kim SH, Jung JY, Kim WJ.
J Toxicol Sci. 2013;38(3):371-8.
Quercetin and epigallocatechin gallate inhibit glucose uptake and metabolism by breast cancer cells by an estrogen receptor-independent mechanism.
Moreira L, Araújo I, Costa T, Correia-Branco A, Faria A, Martel F, Keating E.
Exp Cell Res. 2013 May 9. doi:pii: S0014-4827(13)00195-X. 10.1016/j.yexcr.2013.05.001. [Epub ahead of print]
(-)-Epigallocatechin-3-Gallate, a potential inhibitor to human Dicarbonyl/L-Xylulose Reductase.
Hu XH, Ding LY, Huang WX, Yang XM, Xie F, Xu M, Yu L.
J Biochem. 2013 May 9. [Epub ahead of print]
(-)-Epigallocatechin-3-gallate alleviates spatial memory impairment in APP/PS1 mice by restoring IRS-1 signaling defects in the hippocampus.
Jia N, Han K, Kong JJ, Zhang XM, Sha S, Ren GR, Cao YP.
Mol Cell Biochem. 2013 May 10. [Epub ahead of print]
The effects of ErhBMP-2-/EGCG-coated BCP bone substitute on dehiscence around dental implants in dogs.
Shin YS, Seo JY, Oh SH, Kim JH, Kim ST, Park YB, Moon HS.
Oral Dis. 2013 Apr 8. doi: 10.1111/odi.12109. [Epub ahead of print]
Epigallocatechin-3-Gallate (EGCG) inhibits cell proliferation and migratory behaviour of triple negative breast cancer cells.
Braicu C, Gherman CD, Irimie A, Berindan-Neagoe I.
J Nanosci Nanotechnol. 2013 Jan;13(1):632-7.
Effect of emulsification on the skin permeation and UV protection of catechin.
Yoshino S, Mitoma T, Tsuruta K, Todo H, Sugibayashi K.
Pharm Dev Technol. 2013 May 2. [Epub ahead of print]
EGCG, a major green tea catechin suppresses breast tumor angiogenesis and growth via inhibiting the activation of HIF-1α and NFκB, and VEGF expression.
Gu JW, Makey KL, Tucker KB, Chinchar E, Mao X, Pei I, Thomas EY, Miele L.
Vasc Cell. 2013 May 2;5(1):9. doi: 10.1186/2045-824X-5-9.
Effects of catechin polyphenols and preparations from the plant-parasitic nematode Heterodera glycines on protease activity and behaviour in three nematode species.
Masler EP.
J Helminthol. 2013 May 2:1-8. [Epub ahead of print]
Bioavailability of Antioxidants Applied to Stratified Human Corneal Epithelial Cells.
Stoddard AR, Koetje LR, Mitchell AK, Schotanus MP, Ubels JL.
J Ocul Pharmacol Ther. 2013 May 2. [Epub ahead of print]
[Research on EGCG improving the degenerative changes of the brain in AD model mice induced with chemical drugs].
He M, Liu MY, Wang S, Tang QS, Yao WF, Zhao HS, Wei MJ.
Zhong Yao Cai. 2012 Oct;35(10):1641-4. Chinese.
Green tea epigallocatechin-3-gallate attenuates Porphyromonas gingivalis-induced atherosclerosis.
Cai Y, Kurita-Ochiai T, Hashizume T, Yamamoto M.
Pathog Dis. 2013 Feb;67(1):76-83. doi: 10.1111/2049-632X.12001. Epub 2012 Nov 15.
Epigallocatechin-3-gallate reduces inflammation induced by calcium pyrophosphate crystals in vitro.
Oliviero F, Sfriso P, Scanu A, Fiocco U, Spinella P, Punzi L.
Front Pharmacol. 2013 Apr 17;4:51. doi: 10.3389/fphar.2013.00051. Print 2013.
Epigallocatechin-3-gallate promotes apoptosis and expression of the caspase 9a splice variant in PC3 prostate cancer cells.
Hagen RM, Chedea VS, Mintoff CP, Bowler E, Morse HR, Ladomery MR.
Int J Oncol. 2013 Apr 24. doi: 10.3892/ijo.2013.1920. [Epub ahead of print]
Toward the Molecular Mechanism(s) by Which EGCG Treatment Remodels Mature Amyloid Fibrils.
Palhano FL, Lee J, Grimster NP, Kelly JW.
J Am Chem Soc. 2013 May 22;135(20):7503-10. doi: 10.1021/ja3115696. Epub 2013 May 7.
Anticancer activities of (-)-epigallocatechin-3-gallate encapsulated nanoliposomes in MCF7 breast cancer cells.
de Pace RC, Liu X, Sun M, Nie S, Zhang J, Cai Q, Gao W, Pan X, Fan Z, Wang S.
J Liposome Res. 2013 Apr 19. [Epub ahead of print]
Filters: Manage Filters